Practitioners nationwide are striving to do what’s best for children’s health, while staying supportive in the face of mistrust and confusion.
The use of generative artificial intelligence (AI), able to produce text, images and video on demand, has grown exponentially in recent years. While its applications for personal and professional use ...
LVEF (Left Ventricular Ejection Fraction): Percentage measure of how much blood the left ventricle pumps out with each ...
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. MannKind (NasdaqGM:MNKD) is advancing Afrezza toward ...
MannKind Corporation recently enrolled the first pediatric patient in its INHALE-1ST trial and previously had an FDA supplemental Biologics License Application for Afrezza inhaled insulin in children ...
On February 3, 2026, the President signed the Consolidated Appropriations Act of 2026 (the CAA) into law and ended a partial government shutdown. 1 The Act included two changes that directly affect ...
A review explores how next-generation sequencing may expand newborn screening and highlights key clinical and ethical challenges. Every year, millions of newborns undergo routine screening as a ...
As an alternative to new federal vaccine recommendations, the Itasca-based American Academy of Pediatrics released its own childhood vaccine schedule Monday with the backing of a dozen of the nation’s ...
The Department of Health and Human Services (HHS) recently published Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices. Given current widespread distrust of HHS, ...
According to multiple reports, the FDA is investigating the safety of a pair of already-approved protective treatments for respiratory syncytial virus. The FDA is launching a new safety review of the ...
HHS Secretary Robert F. Kennedy Jr.'s vaccine advisors have set their sights on aluminum adjuvants in vaccines as part of their review of the U.S. pediatric vaccine schedule. While the concept of ...
Acute Lymphoblastic Leukemia (ALL) is the most common pediatric cancer, with significant advancements in treatment leading to over 90% five-year event-free survival rates in developed countries.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results